Forte Biosciences, Inc. (FBRX)
76.94
+0.02
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
76.94
0.00 (0.00%)
After-Hours: 20:00
Forte Biosciences Price to Book Value : 8.574 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.572 |
| August 20, 2026 | 8.569 |
| August 19, 2026 | 8.570 |
| August 18, 2026 | 8.568 |
| August 17, 2026 | 8.569 |
| August 14, 2026 | 8.562 |
| August 13, 2026 | 8.565 |
| August 12, 2026 | 8.556 |
| August 11, 2026 | 8.567 |
| August 10, 2026 | 8.561 |
| August 07, 2026 | 8.558 |
| August 06, 2026 | 8.562 |
| August 05, 2026 | 8.538 |
| August 04, 2026 | 8.532 |
| August 03, 2026 | 8.538 |
| July 31, 2026 | 8.536 |
| July 30, 2026 | 8.579 |
| July 29, 2026 | 8.529 |
| July 28, 2026 | 8.542 |
| July 27, 2026 | 8.525 |
| July 24, 2026 | 6.105 |
| July 23, 2026 | 6.653 |
| July 22, 2026 | 6.311 |
| July 21, 2026 | 5.654 |
| July 20, 2026 | 5.292 |
| Date | Value |
|---|---|
| July 17, 2026 | 5.445 |
| July 16, 2026 | 5.014 |
| July 15, 2026 | 4.920 |
| July 14, 2026 | 4.814 |
| July 13, 2026 | 4.917 |
| July 10, 2026 | 4.894 |
| July 09, 2026 | 4.090 |
| July 08, 2026 | 2.294 |
| July 07, 2026 | 2.480 |
| July 06, 2026 | 2.274 |
| July 02, 2026 | 2.331 |
| July 01, 2026 | 2.376 |
| June 30, 2026 | 2.368 |
| June 29, 2026 | 7.045 |
| June 26, 2026 | 6.949 |
| June 25, 2026 | 6.182 |
| June 24, 2026 | 6.126 |
| June 23, 2026 | 5.997 |
| June 22, 2026 | 6.040 |
| June 18, 2026 | 5.898 |
| June 17, 2026 | 5.812 |
| June 16, 2026 | 5.667 |
| June 15, 2026 | 5.964 |
| June 12, 2026 | 5.802 |
| June 11, 2026 | 5.749 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| argenx SE | -- |
| ACADIA Pharmaceuticals, Inc. | 3.903 |
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| Anika Therapeutics, Inc. | 2.077 |
| Savara, Inc. | 7.957 |
Price to Book Value Related Metrics
| Price | 76.94 |
| Earnings Yield | -6.67% |
| Market Cap | 1.576B |